SABBY MANAGEMENT, LLC - HEPION PHARMACEUTICALS INC ownership

HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 39 filers reported holding HEPION PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of HEPION PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$23,000
-95.9%
20,479
-93.3%
0.00%
-97.3%
Q1 2021$564,000
+216.9%
306,338
+434.5%
0.11%
+307.4%
Q3 2020$178,000
+39.1%
57,309
-21.0%
0.03%
-49.1%
Q1 2020$128,000
-54.0%
72,575
-36.9%
0.05%
-64.7%
Q3 2019$278,000115,0000.15%
Other shareholders
HEPION PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 923,230$2,022,0000.82%
Worth Venture Partners, LLC 233,947$512,0000.40%
PERKINS CAPITAL MANAGEMENT INC 150,000$329,0000.22%
GSA CAPITAL PARTNERS LLP 89,067$195,0000.03%
PREMIER ASSET MANAGEMENT LLC 70,000$153,0000.03%
Allen Capital Group, LLC 23,685$52,0000.01%
ZEKE CAPITAL ADVISORS, LLC 50,000$110,0000.01%
Prospera Financial Services Inc 39,300$86,0000.01%
Onex Canada Asset Management Inc. 20,000$44,0000.00%
Schonfeld Strategic Advisors LLC 95,300$208,0000.00%
View complete list of HEPION PHARMACEUTICALS INC shareholders